[1]尚兰成,常 峰,路 云.药价改革后我国药品价格形势分析——基于我国省际面板数据的实证研究[J].卫生经济研究,2019,(04):59-63.
　SHANG Lan-cheng,CHANG Feng,LU Yun.Analysis of China's Drug Price Situation after Drug Price Reform——An Empirical Study Based on Provincial Panel Data in China[J].Journal Press of Health Economics Research,2019,(04):59-63.
点击复制

药价改革后我国药品价格形势分析
——基于我国省际面板数据的实证研究
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
期数:
2019年04期
页码:
59-63
栏目:
药械管理
出版日期:
2019-03-27

文章信息/Info

Title:
Analysis of China's Drug Price Situation after Drug Price Reform
——An Empirical Study Based on Provincial Panel Data in China
作者:
尚兰成1;  常 峰1; 路 云1
1.中国药科大学国际医药商学院， 江苏 南京 211198
Author(s):
SHANG Lan-cheng; CHANG Feng; LU Yun
School of International Pharmaceutical Business，China Pharmaceutical University，Nanjing Jiangsu 211198，China
关键词:
药品价格改革; 价格指数; 药品类别
Keywords:
drug price reform; price index; drug category
分类号:
R95
文献标志码:
A
摘要:
目的：全面分析我国药品价格形势，为药价改革的进一步开展提供依据。方法：综合运用价格指数、参考价格等方法，基于全国31个省级行政区域2013—2017年的药品中标（挂网）价格，分析我国整体以及各类别药品的价格形势。结果：药价改革后，化学药价格整体呈下降趋势，中成药基本保持平稳；药品招标最高价与最低价之间的价差不断缩小，总体有向价格均值回归的趋势；不同类别药品对药价改革的反应不同——医保甲类药品以及基本药物在药价改革后价格呈明显上涨趋势，且价格上涨的多为疗效优良、价格低廉的药品。结论：药价改革后，我国药品市场价格总体处于较为健康的发展状态，今后应因地制宜，对不同类型药品“具体问题具体对待”，同步推进相关配套政策。
Abstract:
Objective To comprehensively analyze the drug price situation in China and provide a basis for further development of drug price reform. Methods Using price index，reference price and other methods，based on the price of drug-winning (hanging net) in 31 provincial-level administrative regions in China from 2013 to 2017，this paper analyzed the price situation of China's overall and various categories of drugs. Results After the drug price reform，the overall trend of chemical drugs showed a downward trend，and the proprietary Chinese medicines remained basically stable. The price difference between the highest and lowest price of drug bidding continued to shrink，and the trend of the overall directed price average returned. The drug price reform of different categories of drugs responded differently——the price of medical insurance for Class A drugs and essential drugs has increased significantly after the drug price reform. Most of the rises are drugs with good efficacy and low prices. Conclusion After the drug price reform，the price of China's pharmaceutical market is generally in a relatively healthy state of development. In the future，it should be tailored to local conditions，and “special issues should be treated specifically” for different types of drugs，and relevant supporting policies should be promoted simultaneously.

参考文献/References:

[1] 王东进. 关于我国药品价格改革的几点认识与思考[J]. 价格理论与实践,2015(8):5-6.
[2] 张汉东. 中国的药品价格改革和监管——在联合国第七届多边协定公平原则及规则审议大会“药品领域竞争的作用及其给消费者带来的利益”圆桌会议上的发言[J]. 中国价格监管与反垄断,2015(9):4-5.
[3] 谭一蔓. 适时放开药品最高限价 强化市场监管与医保控费——药品价格改革的观点综合述评[J]. 价格理论与实践,2015(4):20-22.
[4] 黄庆明,白大平.我国价格指数的编制方法[J].统计教育,1995(2)：45-46.
[5] 鲍金红,胡璇. 我国现阶段的市场失灵及其与政府干预的关系研究[J]. 学术界,2013(7):182-191，311
. [6] 徐伟,江欣禅,杨爽. 香港地区药物安全网对大病医疗保障的启示[J]. 中国卫生政策研究,2017,10(4):18-23.
[7] 常峰.药品国际参考价格在我国的应用[J].价格理论与实践,2015(7):14-16.
[8] 丁先明. “劣药驱逐良药” 廉价药看得见吃不着[N]. 中国青年报,2011-10-24(5).
[9] 吴静娴,何荣鑫,王雪,等. “三医”联动视角探究我国公立医院医疗服务价格改革[J]. 中国卫生经济,2016,35(7):44-46.
[10] 丁肇启,萧鸣政. 省管县新模式“全面直管”改革政策效果分析——基于河南省的研究[J]. 公共管理学报,2017,14(2):14-25，153.
[11] 马超,顾海,孙徐辉. 医保统筹模式对城乡居民医疗服务利用和健康实质公平的影响——基于机会平等理论的分析[J]. 公共管理学报,2017,14(2):97-109，157.

相似文献/References:

[1]刘朝一,徐 伟,许正圆.基于价格指数的基本药物价格水平研究——以江苏省抗感染类药物为例[J].卫生经济研究,2020,(08):38.
　LIU Chao-yi,XU Wei,XU Zheng-yuan.Study on the Price Level of Essential Drugs Based on Price Index—— Take Anti-infective drugs in Jiangsu Province as an Example[J].Journal Press of Health Economics Research,2020,(04):38.
[2]张迎春,丁俊杰,马光辉.考虑货币购买力的省域综合医疗服务价格差异分析[J].卫生经济研究,2021,38(8):66.
　ZHANG Ying-chun,DING Jun-jie,MA Guang-hui.Analysis on Price Differences of Provincial Comprehensive Medical Services Based on Purchasing Power of Money[J].Journal Press of Health Economics Research,2021,38(04):66.
[3]贾宇飞,于保荣,姜 来.武汉市医疗服务价格指数测算研究[J].卫生经济研究,2023,40(10):26.
　JIA Yufei,YU Baorong,JIANG Lai.Study on the Calculation of Medical Service Price Index in Wuhan[J].Journal Press of Health Economics Research,2023,40(04):26.

更新日期/Last Update: 2019-03-27